|
Mar 29
|
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
|
|
Mar 27
|
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
|
|
Mar 14
|
Is Viatris a Great Dividend Stock or Just a Value Trap?
|
|
Mar 11
|
2 Dirt Cheap Dividend Stocks to Buy and Hold
|
|
Mar 11
|
UPDATE 1-US FDA declines to approve Viatris's injection for multiple sclerosis
|
|
Mar 8
|
Viatris Inc's Dividend Analysis
|
|
Mar 6
|
Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)
|
|
Mar 5
|
Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
|
|
Mar 5
|
13 Best Pharma Dividend Stocks To Buy in 2024
|
|
Mar 4
|
Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise
|
|
Jan 25
|
Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)
|
|
Jan 22
|
12 S&P 500 Stocks On the Move
|
|
Jan 14
|
These 9 Stocks Are Running To Start 2024
|
|
Jan 11
|
Here's Why You Should Invest in Ocuphire Pharma (OCUP) Now
|
|
Dec 27
|
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
|
|
Dec 21
|
Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 7
|
Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?
|
|
Nov 17
|
Top 30 Lowest P/E Ratios of the S&P 500
|
|
Nov 17
|
Why the Cheapest Stock in the S&P 500 Is No Bargain
|
|
Nov 14
|
Viatris to Participate in the Jefferies London Healthcare Conference
|